Mercia Asset Management is an AIM-quoted group with c.£1.4bn of assets under management, operating through private equity, debt and venture capital portfolios.
Portfolio
13
companies
AUM
£1.4B
under management
Adapttech
Adapttech develops wearable biomedical technologies to improve the quality of life for people with physical limitations.
Dxcover
Dxcover develops multiomic spectral analysis technology for early cancer detection.
Expandly
Expandly builds software for managing multi-channel eCommerce operations.
Eyoto
Eyoto develops tele-optometry equipment and optical software for remote eye examinations.
Forensic Analytics
Digital forensics software provider supporting police forces with communications analysis.
HowNow
HowNow operates an artificial intelligence driven learning and skills platform for workplace development.
MIP Diagnostics
MIP Diagnostics develops synthetic antibodies for use in diagnostic devices.
Medherant
Medherant develops novel transdermal drug delivery patches for therapeutic applications.
MindTrace
MindTrace develops unsupervised artificial intelligence systems for autonomous vehicle collision avoidance.
Nova Pangaea Technologies
Nova Pangaea Technologies produces sustainable fuels and cleaner energy solutions.
Sense Biodetection
Sense Biodetection develops rapid molecular diagnostic tests for decentralized healthcare.
Snappy Group
The Snappy Group provides technology platforms connecting consumers with local convenience stores and hospitality venues.
Warwick Acoustics
Warwick Acoustics builds electrostatic loudspeaker technology for automotive audio systems.
Adam Lovell
Adam is a venture capital investor at Mercia Asset Management and holds directorships at CultureAI, Risk Ledger, and Forensic Analytics.
LinkedIn
Angela Warner
Angela brings private equity and venture capital investment experience from roles at Mercia Asset Management, YFM Equity Partners, and Barclays Ventures. She currently serves as Managing Director at Mercia Investments.
LinkedIn
Jonny Nixon
Jonny brings investment and advisory experience from roles at Fyntra Advisory, Mercia Asset Management, and Grant Thornton. He previously served as chief financial officer at Leap AI.
LinkedInThe funding round will support the clinical development of the company's transdermal testosterone patch for post-menopausal women.
"Having the funding in place for the first clinical trial of our testosterone patch for post-menopausal women will enable Medherant to take a major step towards registration of the product and being able to address this significant gap in the options available for women in this very important stage of their lives."
Mercia Asset Management and Pearson backed the Series A round to fund international expansion and team growth.
"Daniela Tsoneva, Investor at Mercia, said: “We are excited to support Nelson and his team in their quest to transform workplace learning. HowNow’s dynamic matching technology ensures users receive the right learning content at the right time. The company is a pioneer in the relatively new but fast-growing learning experience sector and has the potential to become a market leader. The funding will help it expand its global footprint and continue its rapid growth trajectory."
The funding round was backed by a group of existing investors alongside a grant from the European Innovation Council.
"This is a very significant funding milestone in our mission to detect cancer early and improve survival and quality of life for patients. Having demonstrated our multi-cancer capability, we can now focus on building the pipeline of organ-specific tests, beginning with a multi-center study to gain regulatory approval for the brain cancer test. We will also expand our data on colorectal cancer, one of the leading causes of death worldwide, and continue our work on collaborative projects."
The funding round was backed by Par Equity, Mercia Asset Management, and The Northern Powerhouse Partnership.
The biomedical startup has closed a £2.3m Series A round backed by Mercia Asset Management, ACF Investors, Wren Capital and Wealth Club.
"Adapttech brought its first product to market during 2021, successfully securing a number of sales. We are delighted to be supporting the team with a follow-on investment to continue to scale the business and build out the product portfolio."
